<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05610293</url>
  </required_header>
  <id_info>
    <org_study_id>2022-2224-A-2</org_study_id>
    <nct_id>NCT05610293</nct_id>
  </id_info>
  <brief_title>T1 Squamous Cell Carcinomas of the Lip</brief_title>
  <official_title>Tumor Free Survival in T1 Squamous Cell Carcinomas of the Lip Treated With 5mm or 10mm Surgical Margins.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Maastricht University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the risk of recurrence and metastasis in patients&#xD;
      treated with different surgical margins (5mm vs 10mm) for a T1 squamous cell carcinoma of the&#xD;
      lip.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of head and neck tumors, including lip carcinomas, in increasing. Exact&#xD;
      incidences are lacking because in the Dutch National Cancer Registry (NCR) lip carcinomas are&#xD;
      registered both as oral cavity carcinomas and skin carcinomas. In 2021, 136 patients with lip&#xD;
      cancer were registered in the Netherlands. 90% of patients with lip cancer have localized&#xD;
      disease (stage 1) with a 5-year survival rate of more than 90%.&#xD;
&#xD;
      Lip carcinomas usually involve squamous cell carcinomas (SCC). In most cases, the SCC is&#xD;
      located on the sun-exposed lower lip. In approximately 90% of lower lip SCCs, the tumor is&#xD;
      smaller than 2cm in diameter. According to the current eight edition of the Tumor Node&#xD;
      Metastasis (TNM) classification of the American Joint Committee on Cancer (AJCC) and the&#xD;
      ninth edition of the Union for Internation Cancer Control (UICC), it is classified as tumor&#xD;
      stage I.&#xD;
&#xD;
      Surgery is the conventional treatment for a T1 SCC of the lip, where tumor margins can be&#xD;
      verified via histologic examination. A histologic margin of less than 2mm is associated with&#xD;
      an increased risk of local recurrence and metastasis.&#xD;
&#xD;
      In the Netherlands, surgical treatment of lip carcinomas is performed by dermatologists,&#xD;
      plastic and reconstruction surgeons, oral and maxillofacial surgeons (OMFS), and&#xD;
      otorhinolaryngologists (ENT). There is currently no international consensus regarding the&#xD;
      appropriate surgical margins for excision of a T1 SCC on the lip. According to the AJCC, a&#xD;
      surgical margin of 5mm is appropriate, while according to the UICC, a surgical margin of 10mm&#xD;
      is appropriate. Scientific evidence is limited regarding differences in tumor clearance and&#xD;
      the risk of recurrence or metastasis after excision of T1 SCCs with a surgical margin of 5mm&#xD;
      versus 10mm.&#xD;
&#xD;
      We aimed to investigate whether there is a significant difference in tumor-free survival in&#xD;
      patients with surgically treated T1 lip SCC with a surgical margin of 5mm versus 10mm.&#xD;
&#xD;
      A retrospective descriptive multicenter data study will be conducted with four different&#xD;
      centers in the Netherlands (Maastricht University Medical Center+), Radboud University&#xD;
      Medical Center (RadboudUMC) Nijmegen, Catharina Hospital Eindhoven (CZE), and Zuyderland&#xD;
      Medical Center Heerlen/Sittard. Data will be obtained from the Dutch Cancer Registry (NKR)&#xD;
      and the Dutch Pathological Anatomical National Automated Archive (PALGA).&#xD;
&#xD;
      The primary outcome is the difference in tumor-free survival in patients treated with&#xD;
      surgical margins of 5mm and 10mm. The secondary outcome is the difference in tumor-free&#xD;
      survival in patients with different histologic free margins. To evaluate the risk of surgical&#xD;
      and histologic margins on the risk of local recurrence and metastasis, a Kaplan-Meier&#xD;
      analysis, log-rank test and cox-proportional hazard models will be used.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Tumor-free survival surgical margins</measure>
    <time_frame>5 years after surgical treatment</time_frame>
    <description>Difference in tumor-free survival of patients treated with a 5mm surgical margin versus 10mm surgical margin for a T1 SCC on the lip. An event was refered to as the occurrence of recurrence or metastasis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tumor-free survival histologic margins</measure>
    <time_frame>5 years after surgical treatment</time_frame>
    <description>Difference in tumor-free survival of patients with a histologic margin of &lt;2mm versus patients with a histologic margin of 2mm or more of their T1 SCC on the lip.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Lip</condition>
  <condition>Lip Cancer</condition>
  <condition>Lip SCC</condition>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Squamous Cell Carcinoma of the Lip</condition>
  <condition>Surgery</condition>
  <condition>Surgical Margin</condition>
  <condition>Recurrence</condition>
  <condition>Metastasis</condition>
  <condition>Tumor Free Margins</condition>
  <arm_group>
    <arm_group_label>5mm surgical margin</arm_group_label>
    <description>Patients treated with a 5mm surgical margin for a T1 SCC of the lip.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10mm surgical margin</arm_group_label>
    <description>Patients treated with a 10mm surgical margin for a T1 SCC of the lip.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Data from patients are collected retrospectively using data from the Pathological&#xD;
        Anatomical National Automated Archive (PALGA). These are data from patients treated at one&#xD;
        of the following four centers in the Netherlands: MUMC+, Radboudumc, Zuyderland MC, CZE.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients of 18 years and older&#xD;
&#xD;
          -  with a T1 cutaneous squamous cell carcinoma of the lip (including the cutaneous lip,&#xD;
             vermillion border, vermillion and mucosal involvement).&#xD;
&#xD;
          -  who received surgical treatment&#xD;
&#xD;
          -  treated at one of the following centers: Maastricht University Medical Center+&#xD;
             (MUMC+), Radboud University Medical Center (Radboudumc), Zuyderland Medical Center&#xD;
             (Zuyderland MC), Catharina Hospital Eindhoven (CZE).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  malignancies other than cutaneous squamous cell carcinoma&#xD;
&#xD;
          -  Oropharyngeal cancer&#xD;
&#xD;
          -  patients with stage T2-T4 cutaneous squamous cell caricnomas of the lip&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>K Mosterd, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <state>Gelderland</state>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Hospital</name>
      <address>
        <city>Eindhoven</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zuyderland Medical Center</name>
      <address>
        <city>Heerlen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <link>
    <url>https://iknl.nl/nkr-cijfers</url>
    <description>Integral cancer center Netherlands; incidence rates on lip tumors</description>
  </link>
  <reference>
    <citation>Kerawala C, Roques T, Jeannon JP, Bisase B. Oral cavity and lip cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016 May;130(S2):S83-S89. doi: 10.1017/S0022215116000499.</citation>
    <PMID>27841120</PMID>
  </reference>
  <reference>
    <citation>de Visscher JG, Grond AJ, Botke G, van der Waal I. Results of radiotherapy for squamous cell carcinoma of the vermilion border of the lower lip. A retrospective analysis of 108 patients. Radiother Oncol. 1996 Apr;39(1):9-14. doi: 10.1016/0167-8140(96)01716-1.</citation>
    <PMID>8735488</PMID>
  </reference>
  <reference>
    <citation>Kelleners-Smeets NW, Bekkenk MW, de Haas ER. [Skin cancer: from smearing to cutting]. Ned Tijdschr Geneeskd. 2013;157(12):A5602. Dutch.</citation>
    <PMID>23515035</PMID>
  </reference>
  <reference>
    <citation>Biasoli ER, Valente VB, Mantovan B, Collado FU, Neto SC, Sundefeld ML, Miyahara GI, Bernabe DG. Lip Cancer: A Clinicopathological Study and Treatment Outcomes in a 25-Year Experience. J Oral Maxillofac Surg. 2016 Jul;74(7):1360-7. doi: 10.1016/j.joms.2016.01.041. Epub 2016 Jan 30.</citation>
    <PMID>26917204</PMID>
  </reference>
  <reference>
    <citation>de Visscher JG, Gooris PJ, Vermey A, Roodenburg JL. Surgical margins for resection of squamous cell carcinoma of the lower lip. Int J Oral Maxillofac Surg. 2002 Apr;31(2):154-7. doi: 10.1054/ijom.2002.0232.</citation>
    <PMID>12102412</PMID>
  </reference>
  <reference>
    <citation>Joo YH, Cho JK, Koo BS, Kwon M, Kwon SK, Kwon SY, Kim MS, Kim JK, Kim H, Nam I, Roh JL, Park YM, Park IS, Park JJ, Shin SC, Ahn SH, Won S, Ryu CH, Yoon TM, Lee G, Lee DY, Lee MC, Lee JK, Lee JC, Lim JY, Chang JW, Jang JY, Chung MK, Jung YS, Cho JG, Choi YS, Choi JS, Lee GH, Chung PS. Guidelines for the Surgical Management of Oral Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol. 2019 May;12(2):107-144. doi: 10.21053/ceo.2018.01816. Epub 2019 Feb 2.</citation>
    <PMID>30703871</PMID>
  </reference>
  <reference>
    <citation>O'Sullivan B. UICC manual of clinical oncology: John Wiley &amp; Sons; 2015.</citation>
  </reference>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>November 2, 2022</study_first_submitted>
  <study_first_submitted_qc>November 2, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2022</study_first_posted>
  <last_update_submitted>March 23, 2023</last_update_submitted>
  <last_update_submitted_qc>March 23, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Disease free survival</keyword>
  <keyword>Multicenter</keyword>
  <keyword>Histological margin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Lip Neoplasms</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

